Canagliflozin - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Will Iran strikes on Dubai delay Wynn Al Marjan Island and what does it mean for WYNN investors?

Blackstone (NYSE: BX) to acquire majority stake in Advanced Cooling Technologies as AI data centre heat surge reshapes thermal management market

Representative image of enterprise data center infrastructure and networking hardware illustrating Hewlett Packard Enterprise’s fiscal 2026 growth momentum, as strong networking revenue following the Juniper Networks acquisition drives higher earnings, improved free cash flow, and renewed investor focus on HPE’s evolving AI and infrastructure strategy.

Hewlett Packard Enterprise (NYSE: HPE) raises FY2026 guidance after Q1 beat fuelled by Juniper integration and AI networking demand

Representative image: Oracle (NYSE: ORCL) stock jumps 13% on record cloud earnings and multicloud momentum

Oracle (NYSE: ORCL) rallies 10% after earnings as $553bn RPO signals AI infrastructure dominance

Zydus Lifesciences gets FDA tentative approval for Invokamet generic

Read More

1 minute read

Pharma Industry News

Zydus Lifesciences gets FDA tentative approval for Invokamet generic

Zydus Lifesciences said that its subsidiary Zydus Pharmaceuticals (USA) has been granted tentative approval for Canagliflozin and Metformin…

byPallavi Madhiraju

February 22, 2023

web analytics